EC Healthcare (2138.HK)
HKD 0.7
(-1.41%)
HKD 0.7
(-1.41%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.05 Billion HKD | 27.68% |
| 2022 | 822.4 Million HKD | 1001.44% |
| 2021 | 74.66 Million HKD | -24.08% |
| 2020 | 98.34 Million HKD | -50.7% |
| 2019 | 199.46 Million HKD | 12.36% |
| 2018 | 177.51 Million HKD | -33.14% |
| 2017 | 265.49 Million HKD | 232.94% |
| 2016 | -199.71 Million HKD | 43.7% |
| 2015 | -354.71 Million HKD | -173.1% |
| 2014 | -129.88 Million HKD | -158.83% |
| 2013 | -50.18 Million HKD | -36.03% |
| 2012 | -36.89 Million HKD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q4 | 1.05 Billion HKD | 16.92% |
| 2023 Q2 | 898.11 Million HKD | 9.2% |
| 2023 FY | 1.05 Billion HKD | 27.68% |
| 2022 Q4 | 822.4 Million HKD | 41.28% |
| 2022 FY | 822.4 Million HKD | 1001.44% |
| 2022 Q2 | 582.12 Million HKD | 679.63% |
| 2021 Q4 | 74.66 Million HKD | 110.95% |
| 2021 Q2 | -681.8 Million HKD | -793.28% |
| 2021 FY | 74.66 Million HKD | -24.08% |
| 2020 Q2 | 453.3 Thousand HKD | -99.77% |
| 2020 Q4 | 98.34 Million HKD | 21595.22% |
| 2020 FY | 98.34 Million HKD | -50.7% |
| 2019 FY | 199.46 Million HKD | 12.36% |
| 2019 Q4 | 199.46 Million HKD | -15.65% |
| 2019 Q2 | 236.47 Million HKD | 33.21% |
| 2018 Q4 | 177.51 Million HKD | -28.79% |
| 2018 FY | 177.51 Million HKD | -33.14% |
| 2018 Q2 | 249.27 Million HKD | -6.11% |
| 2017 Q4 | 265.49 Million HKD | 218.85% |
| 2017 FY | 265.49 Million HKD | 232.94% |
| 2017 Q2 | -223.39 Million HKD | -11.85% |
| 2016 Q2 | -544.17 Million HKD | -53.41% |
| 2016 FY | -199.71 Million HKD | 43.7% |
| 2016 Q4 | -199.71 Million HKD | 63.3% |
| 2015 FY | -354.71 Million HKD | -173.1% |
| 2015 Q4 | -354.71 Million HKD | -9.57% |
| 2015 Q2 | -323.72 Million HKD | -149.24% |
| 2014 FY | -129.88 Million HKD | -158.83% |
| 2014 Q4 | -129.88 Million HKD | 0.0% |
| 2013 FY | -50.18 Million HKD | -36.03% |
| 2012 FY | -36.89 Million HKD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 27.54 Million HKD | -3712.34% |
| Innovative Pharmaceutical Biotech Limited | 914.37 Million HKD | -14.84% |
| China Overseas Nuoxin International Holdings Limited | 9.99 Million HKD | -10410.169% |
| Prosperous Future Holdings Limited | -337.41 Million HKD | 411.21% |
| Huasheng International Holding Limited | 175.03 Million HKD | -499.914% |
| Fourace Industries Group Holdings Limited | -250.33 Million HKD | 519.47% |
| Evergreen Products Group Limited | 430.83 Million HKD | -143.729% |
| Ming Fai International Holdings Limited | -329.49 Million HKD | 418.696% |
| Blue Moon Group Holdings Limited | -4.18 Billion HKD | 125.1% |
| SuperRobotics Holdings Limited | 126.44 Million HKD | -730.483% |
| Takbo Group Holdings Limited | -175.44 Million HKD | 698.536% |
| Hyfusin Group Holdings Limited | -318.4 Million HKD | 429.787% |